Orkla India Q2 FY27: consolidated PAT +19% YoY to ₹91.4 Cr, margins hold steady

Orkla India's consolidated revenue rose 19.4% YoY to ₹776.16 Cr (also up 17.8% QoQ from ₹659.10 Cr), with PAT up 19.2% YoY to ₹91.42 Cr and basic EPS up 19.6% YoY to ₹6.7. Net profit margin was essentially flat YoY at 11.62% versus 11.61% a year ago — growth came through without diluting profitability. There were no exceptional items in either the current or year-ago quarter, so reported and adjusted growth are the same. Standalone PAT came in at ₹89.59 Cr, about 2% below the consolidated number, a gap consistent with the subsidiary/JV contribution rather than any divergence in the underlying story.

Sequentially, margins did ease — NPM fell from 12.97% in Q1 FY27 to 11.62% this quarter even as revenue grew a faster 17.8% QoQ, with PAT up a much more modest 4.2% QoQ. The cost bridge points to higher stock-in-trade purchases (₹123.58 Cr consolidated versus ₹98.72 Cr standalone), a gap tied to the subsidiary Orkla IMEA Trading LLC, consistent with management's stated international-expansion driver; raw material and employee costs moved in line with the topline. This reads as a sequential, investment-led dip rather than a YoY margin problem.

The stock went into the print at ₹530, down 1.7% over the past month of trading.

For context: this is the highest quarterly PAT in the last 5 quarters on our records; PAT has now risen for 3 consecutive quarters; revenue is at a 5-quarter high.

No exceptional items this quarter, versus a ₹1.5 Cr labour-code write-back in Q1 FY27

No formal analyst consensus for this specific quarter could be confirmed via search, so street positioning is unknown; broader FY27 full-year revenue consensus (~₹2,780 Cr) and recent brokerage buy ratings suggest the stock is tracked, but no Q2-specific preview numbers surfaced. On the corporate side, the board reconstituted its Nomination & Stakeholders Committees and named Maria Syse-Nybraaten as Chairperson following the prior Chairman's resignation (October 27, 2026), both concurrent with results; the company also publicly denied speculative news of a Farmley transaction (October 12, 2026). MTR Foods expanded its sweets portfolio with eight new products (October 8, 2026), feeding the convenience-food growth driver management has repeatedly cited.